CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity

Abstract

These data collectively underscore the importance of the release of CX3CL1 in eliciting an immunogenic response against dying cancer cells and suggest that CX3CL1 may serve as a key switch in conferring immunogenicity to apoptosis.